Virtu Financial’s Citius Oncology CTOR Stock Holding History

Virtu Financial’s Portfolio CTOR Stock Details CTOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14K	Buy	+21,877	New	+$17.4K	﹤0.01%	1401
2024 Q4	–	Sell	-10,291	Closed	-$14K	–	2187
2024 Q3	$14K	Sell	10,291 -17,817	-63%	-$126K	﹤0.01%	1166
2024 Q2	$319K	Sell	28,108 -426	-1%	-$4.78K	0.02%	581
2024 Q1	$316K	Buy	+28,534	New	+$314K	0.02%	597
2023 Q4	–	Sell	-12,128	Closed	-$130K	–	2092
2023 Q3	$130K	Sell	12,128 -30,290	-71%	-$323K	0.01%	771
2023 Q2	$447K	Buy	42,418 +32,068	+310%	+$335K	0.03%	435
2023 Q1	$108K	Buy	+10,350	New	+$106K	0.01%	958

Other funds holding CTOR

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Virtu Financial's CTOR Position: Q2 2026 in Review

Virtu Financial opened a new position in Citius Oncology (CTOR) in Q2 2026: 21,877 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #1401 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CTOR as recently as Q3 2024.

Virtu Financial first reported a position in CTOR in Q1 2023 and has held it in 7 quarters since. The position peaked at $447K in Q2 2023. 19 funds tracked by Wall St. Rank hold CTOR as of Q2 2026.

Virtu Financial held 21,877 shares of Citius Oncology worth $14K as of Q2 2026.
Citius Oncology was a new Virtu Financial position in Q2 2026.
Citius Oncology made up ﹤0.01% of Virtu Financial's portfolio in Q2 2026, its #1401 holding.
Virtu Financial first reported a position in Citius Oncology in Q1 2023 and has held it in 7 quarters since.
Virtu Financial's Citius Oncology position peaked at $447K in Q2 2023.
19 funds tracked by Wall St. Rank held Citius Oncology as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.